Coya Therapeutics, Inc. Contracts & Agreements
31 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (2)
- Human Resources (9)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Uncategorized (7)
- Executive Employment Agreement by and between the Company and Arun Swaminathan, dated April 3, 2023 (Filed With SEC on August 19, 2024)
- First Amendment to DRL Development Agreement, dated June 4, 2024 (Filed With SEC on June 5, 2024)
- Purchase Agreement dated May 17, 2024, by and between the Company and the ADDF (Filed With SEC on May 20, 2024)
- Amendment No.1 to the Amended and Restated Coya Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on May 8, 2024)
- Development and License Agreement by and among Coya Therapeutics, Inc., Dr. Reddy's Laboratories SA, and Dr. Reddy's Laboratories Ltd., dated December 5, 2023 (Filed With SEC on March 19, 2024)
- Description of Securities of Coya Therapeutics, Inc (Filed With SEC on March 19, 2024)
- Form of Securities Purchase Agreement, by and among the Company and the Purchasers (Filed With SEC on December 6, 2023)
- Form of Newbridge/Allele Warrant (Filed With SEC on December 6, 2023)
- Amended and Restated Employment Agreement, dated July 11, 2023, between the Company and Dr. Fred Grossman (Filed With SEC on July 14, 2023)
- Employment Agreement, dated July 3, 2023, between the Company and Dr. Fred Grossman (Filed With SEC on July 10, 2023)
- Form of Warrant Agency Agreement between Coya Therapeutics, Inc. and Computershare Limited(d) (Filed With SEC on December 13, 2022)
- Form of Underwriters Warrant(d) (Filed With SEC on December 13, 2022)
- Form of Underwriting Agreement(d) (Filed With SEC on December 13, 2022)
- The Amended and Restated Coya Therapeutics, Inc. 2021 Equity Incentive Plan(b)(d) (Filed With SEC on December 5, 2022)
- Form of Common Stock Purchase Warrant to be issued in this offering(d) (Filed With SEC on December 5, 2022)
- Convertible Note Placement Agent Warrant(d) (Filed With SEC on November 18, 2022)
- Agreement and Plan of Merger by and among Coya Therapeutics, Inc. and Nicoya Health, Inc. dated December 22, 2020(d) (Filed With SEC on November 18, 2022)
- Series A Placement Agent Warrant(d) (Filed With SEC on November 18, 2022)
- License Agreement by and between Coya Therapeutics, Inc. and ARScience Biotherapeutics, Inc., dated August 23, 2022. (c)(d) (Filed With SEC on November 18, 2022)
- Material Transfer and Option Agreement, dated June 24, 2022, by and between Coya Therapeutics, Inc. and Carnegie Mellon University(c)(d) (Filed With SEC on November 18, 2022)
- Second Amendment to Sponsored Research Agreement, dated February 4, 2022, by and between Coya Therapeutics, Inc. and The Methodist Hospital Research Institute d/b/a Houston... (Filed With SEC on November 18, 2022)
- First Amendment to Sponsored Research Agreement, dated February 4, 2022, by and between Coya Therapeutics, Inc. and The Methodist Hospital Research Institute d/b/a Houston... (Filed With SEC on November 18, 2022)
- Sponsored Research Agreement, dated February 3, 2021, by and between Coya Therapeutics, Inc. and The Methodist Hospital Research Institute d/b/a Houston Methodist Research... (Filed With SEC on November 18, 2022)
- Amended and Restated Patent Know How and License Agreement, effective as of October 6, 2020, by and between Coya Therapeutics, Inc. and The Methodist Hospital(c)(d) (Filed With SEC on November 18, 2022)
- Executive Employment Agreement, dated November 1, 2021, by and between Coya Therapeutics, Inc. and Adrian Hepner(b)(d) (Filed With SEC on November 18, 2022)
- Executive Employment Agreement, dated March 14, 2022, by and between Coya Therapeutics, Inc. and David Snyder(b)(d) (Filed With SEC on November 18, 2022)
- Employment Agreement Addendum, dated April 1, 2022, by and between Coya Therapeutics, Inc. and Howard Berman (b)(c)(d) (Filed With SEC on November 18, 2022)
- Executive Employment Agreement, dated December 15, 2020, by and between Coya Therapeutics, Inc. and Howard Berman(b)(d) (Filed With SEC on November 18, 2022)
- Form of Indemnification Agreement to be entered into by Coya Therapeutics, Inc. with its Officers and Directors(b)(d) (Filed With SEC on November 18, 2022)
- First Amended Investors Rights Agreement dated as of March 4, 2022, by and among Coya Therapeutics, Inc. and certain holders of its capital stock(c)(d) (Filed With SEC on November 18, 2022)
- Form of Specimen common stock certificate(d) (Filed With SEC on November 18, 2022)
